Cidara Therapeutics: $11.1M European Approval Milestone
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
- Latest
- Trending
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...
Hasbro is set to release its Q4 results, with a predicted profit increase but a 20% decline in revenue. Analysts ...
Loop Capital downgrades FMC Corp. to Hold and lowers price target due to inventory challenges in critical markets. Concerns over ...
Investment company Investcorp plans to list a portfolio company in the Gulf region by 2024, with optimism for completion in ...
Pushd (PUSHD) is gaining attention for its user-friendly features and potential for growth in the cryptocurrency market. With over 25,500 ...
Investors are closely watching New York Community Bancorp as concerns grow over their exposure to commercial real estate. The recent ...
Emeren Group has launched a $10M accelerated stock repurchase program, aiming to increase shareholder value and strengthen its position in ...
U.S. regulators have raised concerns over Citigroup's default risk measurement and urged the bank to make immediate changes. Citigroup's internal ...
Microsoft is reportedly developing an AI upscaling feature for PC games on Windows 11, similar to Nvidia's DLSS technology. This ...
Venture capital firm Sora Ventures has launched a $2 million liquid fund for projects within the TTP ecosystem, with support ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.